Skip to main content
. Author manuscript; available in PMC: 2014 Jul 7.
Published in final edited form as: Mol Pharm. 2013 Mar 13;10(4):1299–1305. doi: 10.1021/mp300449t

Figure 4.

Figure 4

Biological performance of PR+:siRNA complexes. (A) Relative cell viabilities PR+ and bPEI as a function of amine densities in 10% serum-supplemented media; (B) relative cellular uptakes of PR+ and bPEI with L2k as positive control; and (C) in vitro GFP knockdown efficiencies of 2k, 3.4k and 10k PR+:siRNA complexes in 10% serum-supplemented media with L2k and bPEI as controls.